1. Home
  2. Analysis
  3. Korlym
  4. Celexa

Korlym and Celexa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Korlym (mifepristone) and Celexa (citalopram hydrobromide). Common drug interactions include nausea among females.

The phase IV clinical study analyzes what interactions people have when they take Korlym and Celexa. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

On Aug, 13, 2026

22 people who take Korlym and Celexa together, and have interactions are studied.

Korlym and Celexa drug interactions.

What are the common drug interactions of Korlym and Celexa, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Decreased appetite
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Face oedema (swelling of face)
  5. Pneumonia
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Visual impairment
  8. Vomiting
  9. Blood potassium decreased
  10. Abdominal pain lower

male:

n/a

What are the common drug interactions of Korlym and Celexa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Abdominal pain lower
  3. Asthenia (weakness)
  4. Burning sensation
  5. Constipation
  6. Decreased appetite
  7. Dizziness
  8. Gastritis (inflammation of stomach)
  9. Pruritus (severe itching of the skin)
  10. Chills (felling of cold)

50-59:

  1. Tremor (trembling or shaking movements in one or more parts of your body)
  2. Blood glucose decreased
  3. Blood potassium decreased
  4. Chills (felling of cold)
  5. Rash
  6. Somnolence (a state of near-sleep, a strong desire for sleep)
  7. Weight increased

60+:

  1. Blood pressure increased
  2. Cardiac failure congestive
  3. Pneumonia
  4. Visual impairment
  5. Blood calcium decreased
  6. Blood potassium decreased
  7. Burning sensation
  8. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  9. Pain
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 17 people, 77.27%
  2. Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 4 people, 18.18%
  3. Type 2 Diabetes: 3 people, 13.64%
  4. Essential Hypertension (primary hypertension): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Korlym and Celexa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Korlym and Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celexa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on mifepristone and citalopram hydrobromide (the active ingredients of Korlym and Celexa, respectively), and Korlym and Celexa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.